NO171295C - PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF A BIOLOGICALLY ACTIVE CONJUGATED PROTEIN - Google Patents

PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF A BIOLOGICALLY ACTIVE CONJUGATED PROTEIN

Info

Publication number
NO171295C
NO171295C NO870779A NO870779A NO171295C NO 171295 C NO171295 C NO 171295C NO 870779 A NO870779 A NO 870779A NO 870779 A NO870779 A NO 870779A NO 171295 C NO171295 C NO 171295C
Authority
NO
Norway
Prior art keywords
preparing
procedure
biologically active
pharmaceutical preparation
conjugated protein
Prior art date
Application number
NO870779A
Other languages
Norwegian (no)
Other versions
NO870779L (en
NO171295B (en
NO870779D0 (en
Inventor
Nandini Katre
Michael James Knauf
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1986/001252 external-priority patent/WO1987000056A1/en
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of NO870779L publication Critical patent/NO870779L/en
Publication of NO870779D0 publication Critical patent/NO870779D0/en
Publication of NO171295B publication Critical patent/NO171295B/en
Publication of NO171295C publication Critical patent/NO171295C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A61K47/6827—Ricin A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO870779A 1985-06-26 1987-02-25 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF A BIOLOGICALLY ACTIVE CONJUGATED PROTEIN NO171295C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74995585A 1985-06-26 1985-06-26
PCT/US1986/001252 WO1987000056A1 (en) 1985-06-26 1986-06-06 Solubilization of proteins for pharmaceutical compositions using polymer conjugation

Publications (4)

Publication Number Publication Date
NO870779L NO870779L (en) 1987-02-25
NO870779D0 NO870779D0 (en) 1987-02-25
NO171295B NO171295B (en) 1992-11-16
NO171295C true NO171295C (en) 1993-02-24

Family

ID=26773725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870779A NO171295C (en) 1985-06-26 1987-02-25 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF A BIOLOGICALLY ACTIVE CONJUGATED PROTEIN

Country Status (2)

Country Link
AU (1) AU580431B2 (en)
NO (1) NO171295C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
CA1283046C (en) * 1986-05-29 1991-04-16 Nandini Katre Tumor necrosis factor formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4414147A (en) * 1981-04-17 1983-11-08 Massachusetts Institute Of Technology Methods of decreasing the hydrophobicity of fibroblast and other interferons
EP0154316B1 (en) * 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof

Also Published As

Publication number Publication date
NO870779L (en) 1987-02-25
AU580431B2 (en) 1989-01-12
AU5970086A (en) 1987-01-30
NO171295B (en) 1992-11-16
NO870779D0 (en) 1987-02-25

Similar Documents

Publication Publication Date Title
FI870809A0 (en) Process for preparing a biologically active, conjugated protein useful in pharmaceutical preparation
KR910700249A (en) New therapeutically active compounds and methods for their preparation
NO903264L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF MICROPARTICLES.
NO863670D0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION OF A HYDROPHOBIC MEDICINE.
NO882103D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
NO173486C (en) Procedure for Preparing a Pharmaceutical Preparation for Transdermal Drug Administration
DK362189D0 (en) PHARMACEUTICAL PREPARATION FOR INTRAVENOES ADMINISTRATION
DK489189A (en) PHARMACEUTICAL PREPARATION
NO864425L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLYL-OXOFTALAZINYL-ACETIC ACID DERIVATIVES
NO934897L (en) Procedure for Preparing a Pharmaceutical Preparation
KR900700492A (en) N-heterocyclic propylidene-1,1-bisphosphonic acid, preparation method thereof and pharmaceutical composition
NO173590C (en) Process for the preparation of a stable nicorandil-containing pharmaceutical composition
NO862141L (en) PROCEDURE FOR THE PREPARATION OF ACTIVE CINNOLINE DERIVATIVES
NO863373D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINO ACID DERIVATIVES.
DK603988D0 (en) PHARMACEUTICAL PREPARATION
DK336489A (en) PHARMACEUTICAL PREPARATION
DK298389D0 (en) PHARMACEUTICAL PREPARATION FOR TOPICAL USE INCLUDING AN AMINE-FUNCTIONAL MEDICINE
NO171295C (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF A BIOLOGICALLY ACTIVE CONJUGATED PROTEIN
DK139388D0 (en) PHARMACEUTICAL PREPARATION
DK370085A (en) ANTIANAPHYLACTIC ACTIVE PHARMACEUTICAL PREPARATIONS
NO172491C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANE-ALCOHIC ACID DERIVATIVES
DK276288A (en) PHARMACEUTICAL PREPARATION
NO168357C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DISULFIDES
NO167801C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,2'-BI-1H IMIDAZOLD DERIVATIVES.
NO168473C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENYLTHIAZOLONES.

Legal Events

Date Code Title Description
MK1K Patent expired